|
 VC & Large Device-
Participating VC and Large Device Companies
- Start-Up Presenters
-
Alfa Thermodiagnostics, Inc.
Has designed and patented an improved Whole-Body Thermometry (WBT) advanced medical diagnostic device for ease of use and worldwide adoption.
-
Axial Biotech, Inc.
A private, venture-backed molecular diagnostics company whose mission is to deliver breakthrough diagnostics that improve and personalize the treatment of spine disorders.
-
BeneChill, Inc.
BeneChill is the leader in the field of Hypothermia treatment of the brain for any form of Cerebral Ischemia.
-
BioSculpture Technology, Inc.
BioSculpture Technology is a commercial-stage medical device company with body sculpting products also addressing the bariatric market and autograft processing.
-
Brainsway
Deep Transcranial Magnetic Stimulation (Deep TMS) that enables noninvasive activation of deep brain structures for the effective treatment of a broad range of brain disorders.
-
Cerebid Technologies LLC
A colorimetric blast dosimeter that provides immediate information of the level of blast exposure relative to brain injury via a color change that can be seen with the naked eye.
-
Consensus Orthopedics
Consensus Orthopedics designs, manufactures and sells high quality reconstructive total joint implants for the hip and knee in 11 countries.
-
Cortical Dynamics Ltd.
A medical device company focused on developing the next generation of brain function monitors by employing the latest theories and technologies to the field.
-
Diabetes Sentry Products, Inc.
Diabetes Sentry, the only non-invasive medical device that detects the onset of hypoglycemia, a major life-threatening condition of diabetes.
-
Discovery Technology International, LLP
DTI's piezoelectric motors provide a high performance cost-effective alternative to traditional motors used in medical devices, including flow-control/delivery systems and MRI.
-
Enox BioPharma, Inc.
Enox has a proprietary technology to embed nitric oxide, part of the innate immune system, into polymers with application to medical devices and wound healing.
-
Freedom Meditech, Inc.
The ClearPath DS-120 is a proprietary ophthalmic diagnostic device that early detects diabetes non-invasively before serious complications.
-
Health-Chem Diagnostics
Health-Chem Diagnostics' TD Glucose system will bring a noninvasive glucose test for use by diabetics to the global market.
-
Implandata Ophthalmic Products GmbH
A Germany-based, early-stage, privately held medical device company that has developed a novel technology for 24-hour monitoring of intraocular pressure for the management of glaucoma patients.
-
Invuity, Inc.
Invuity develops medical devices to dramatically improve visualization in less invasive surgeries. The company's products incorporate its proprietary Eigr illumination technology into advanced access systems.
-
Juneau Biosciences LLC
Juneau develops and commercializes proprietary DNA-based diagnostic tests which will revolutionize the care of serious, debilitating diseases impacting women.
-
LumaMed
LumaMed provides real time intraoperative fluorescence polarization images that can help a surgeon better evaluate tumor margins for breast, skin and oral cancers during surgery.
-
LoneStar Heart, Inc.
Develops therapies to restore adequate heart function in Advanced Heart Failure patients. Its lead product, an implantable biopolymer classified as a device, is in efficacy trials in Europe and Australia.
-
Magneceutical Health
Provides whole body magnetic resonance therapy for pain, with a technology that is affordable, effective, easy and natural.
-
Nano Interface Technology, Inc.
An ultra-pure, nanotechnology-based hydroxyapatite technology for use as an orthopedic, spinal disc and dental implant coating, and a bone void filler, to speed recovery, increase bonding strength and reduce revision surgeries.
-
Neurowave Systems, Inc.
NeuroSENSE measures anesthetic/sedative effects on the brain using EEG to help clinicians administer to the patient's exact needs, avoiding adverse outcomes from under- and over-dosing.
-
NexHand
NexHand is developing highly innovative force measurement devices to improve the diagnosis and the surgical procedure to better treat patients suffering from stress urinary incontinence.
-
NinePoint Medical, Inc.
Developing the Nvision VLE Imaging System to enable physicians and pathologists, for the first time, to view high-resolution, volumetric images of organs and tissues in real-time.
-
PCAsso Diagnostics LLC
PolyChromatic Angiography (PCA) is the first quantitative angiography. PCA utilizes a contrast agent composed of a mixture of colors loaded on particles of different sizes to provide quantitative analysis of vascular leakage in the retina.
-
Peytant Solutions, Inc.
A bio-medical device company focused on integrating human biologics with bioabsorbable and alloy implant technologies. The company's bio-incorporable Allo-Endograft System addresses the benign and malignant nonvascular and peripheral vascular patency markets.
-
Poiesis Medical LLC
Offers the Duette double-balloon urinary drainage catheter designed to prevent catheter cystitis, urinary tract infections and septicemia.
-
ReShape Medical
ReShape Duo is an intragastric balloon designed for weight loss, without the risks of surgery or side effects of drugs.
-
Sensimed AG
The SENSIMED Triggerfish is a paradigm-changing solution for continuous monitoring of fluctuations in intra-ocular pressure to manage glaucoma patients.
-
Smart Perfusion LLC
Smart Perfusion's mission is to eliminate the liver and kidney transplant wait list by increasing the number of available organs.
-
StandUp Traction Systems, Inc.
STS has developed a patented vertical lumbar traction system, which has proven superior pain relief to all other forms of lumbar traction, due to its 3x greater vertebral distraction.
-
Surgical Innovations LLC
The MASTR by Surgical Innovations is the first of future designs for low profile, single use/disposable self-retaining atraumatic surgical retractors.
-
Vantix Ltd.
Offers the Vantix point-of-care blood analyzer, in which a pin prick blood sample is placed on a disposable cartridge and inserted into a reader, with lab-quality results in 5 minutes.
Current Presenter Count: 31
- Conference Photos
-
IN3 Conference Photos
Check Out These Photos From Past IN3 Conferences
- Future Conferences
-
New Location!
London, United Kingdom
April 25-26, 2012
Millennium Gloucester Hotel
Boston, MA / USA
June 27-29, 2012
Hyatt Regency Boston
San Francisco, CA / USA
October 15-17, 2012
Intercontinental Mark Hopkins
Grow Your Medical Technology Business Through Financing, M&A, and Strategic Partnerships
Elsevier Business Intelligence, the publishers of the "The Gray Sheet," IN VIVO, START-UP and MedTech Insight is pleased to announce IN3 Medical Device 360° Orlando.
This must-attend event will bring together investment leaders, emerging medtech company management teams, mid-sized and large device company business development teams, patent and copyright firms, regulatory officials and other noteworthy service providers for a full two days of start-up and investor presentations, private partnering meetings and key plenary/panel sessions.
Don't miss this year's program highlights:
-
Making the Pitch: What Do Dealmakers Want? (2 Parts)
In this interactive session, business development executives share their insights and perspectives based on actual company presentations, offering insights on what they like to see from smaller venture-backed companies.
-
Special Featured Panel Discussion for Medical Device Innovators
Angels, Grants and Venture Debt: Alternative Financing Strategies for those Seeking Funding in Today's Difficult Marketplace.
-
VC Meet & Greet: Network with Top VCs and Business Development Executives
If you are a VC and/or Business Development Executive, this is a must attend event. This session, through facilitated meetings, brings VCs and business development executives together to better understand each others' needs.
IN3 Medical Device 360° Orlando will benefit all players in the device space:
As an Early-, Mid- or Late-Stage Start-Up Seeking Investment or Partnership: Present to our audience of key decision makers in investment, corporate business development and venture capital, and advance your company to the next level.
As an Investor: Meet the management teams and hear pitches from more than 35 carefully selected, innovative start-ups poised to transform existing markets or create new ones.
As a Mid-Size Medical Device Company: Learn about key drivers and limiters to your growing business, meet potential partners to help you through clinical trials and onto the market, and assess acquisition targets.
As a Large Medical Device Company: Assess a myriad of opportunities to expand your company's portfolio and ensure a healthy pipeline in 2012 and beyond.
As a Service Provider: Gain exposure to innovators and market leaders who are seeking quality partners and outsourcing to bring their companies and products to the next level.
|
|